CD4+ T Cell Responses in the Immune Control Against Latent Infection by Epstein-Barr Virus

By  

Current Molecular Medicine, Vol. 3, Iss. 4, 2003-06 ,pp. : 341-347

Bentham Science Publishers

Access to resources Recommend Favorite

Evidence for a Type 2 Bias in the CD8 + T-Cell Response to Epstein-Barr Virus Following Heart Transplantation

By Cannon M.J.   Reed L.D.   Mawulawde K.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1136-1139

Elsevier

Access to resources Recommend Favorite

Influence of Epstein–Barr virus infection in adult T-cell leukemia

By Ueda Satomi   Maeda Yasuhiro   Yamaguchi Terufumi   Hanamoto Hitoshi   Hijikata Yasuki   Tanaka Miyako   Takai Shunsuke   Hirase Chikara   Morita Yasuyoshi   Kanamaru Akihisa  

Hematology, Vol. 13, Iss. 3, 2008-06 ,pp. : 154-162

Maney Publishing

Access to resources Recommend Favorite

A panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4 + T cells restricted by prevalent HLA-DR alleles

By Butler Marcus O.   Ansn Sascha   Tanaka Makito   Imataki Osamu   Berezovskaya Alla   Mooney Mary M.   Metzler Genita   Milstein Matthew I.   Nadler Lee M.   Hirano Naoto  

International Immunology, Vol. 22, Iss. 11, 2010-11 ,pp. : 863-873

Oxford University Press

Access to resources Recommend Favorite

CD4 + T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis

By Wilson A.  

International Immunology, Vol. 10, Iss. 8, 1998-08 ,pp. : 1149-1157

Oxford University Press

Access to resources Recommend Favorite